Janney Montgomery Scott LLC lowered its position in shares of Genpact Limited (NYSE:G – Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,943 shares of the business services provider’s stock after selling 536 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Genpact were worth $685,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. SG Americas Securities LLC bought a new position in shares of Genpact in the fourth quarter worth $238,000. Phillips Wealth Planners LLC acquired a new stake in Genpact during the fourth quarter worth about $201,000. Crossmark Global Holdings Inc. increased its holdings in Genpact by 1.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 396,264 shares of the business services provider’s stock valued at $17,020,000 after buying an additional 6,275 shares during the period. MassMutual Private Wealth & Trust FSB raised its position in shares of Genpact by 22.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock valued at $145,000 after buying an additional 619 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after acquiring an additional 433 shares during the period. Institutional investors own 96.03% of the company’s stock.
Genpact Price Performance
Shares of G opened at $54.98 on Friday. The firm has a market cap of $9.70 billion, a PE ratio of 15.10, a price-to-earnings-growth ratio of 1.61 and a beta of 1.20. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76. The business’s 50 day moving average price is $44.92 and its two-hundred day moving average price is $41.15. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.24%. Genpact’s dividend payout ratio is presently 16.76%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on the company. Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday. Robert W. Baird upped their price objective on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and increased their target price for the stock from $45.00 to $60.00 in a report on Friday. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $47.63.
View Our Latest Stock Analysis on Genpact
Insider Buying and Selling at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,058 shares of company stock valued at $1,558,675. Corporate insiders own 2.80% of the company’s stock.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is a Dividend King?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.